Plasminogen‐stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin‐activated cell signalling

The conversion of plasminogen into plasmin by interstitial urokinase plasminogen activator (uPA) is potentially important in asthma pathophysiology. In this study, the effect of uPA‐mediated plasminogen activation on airway smooth muscle (ASM) cell proliferation was investigated.

[1]  M. Schuliga,et al.  Transforming growth factor-β-induced differentiation of airway smooth muscle cells is inhibited by fibroblast growth factor-2. , 2013, American journal of respiratory cell and molecular biology.

[2]  Bihui Huang,et al.  The Annexin A2/S100A10 System in Health and Disease: Emerging Paradigms , 2012, Journal of biomedicine & biotechnology.

[3]  J. Quigley,et al.  Cell Surface Remodeling by Plasmin: A New Function for an Old Enzyme , 2012, Journal of biomedicine & biotechnology.

[4]  G. Høyer-Hansen,et al.  Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo , 2012, Front. Pharmacol..

[5]  M. Blackman,et al.  Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model. , 2012, Experimental and molecular pathology.

[6]  Q. Hamid,et al.  Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  E. Jaffee,et al.  Annexin A2 is a new antigenic target for pancreatic cancer immunotherapy , 2012, Oncoimmunology.

[8]  I. Sayers,et al.  uPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium , 2011, Thorax.

[9]  P. Madureira,et al.  The role of the annexin A2 heterotetramer in vascular fibrinolysis. , 2011, Blood.

[10]  Stephen P. H. Alexander,et al.  Guide to Receptors and Channels (GRAC), 5th edition , 2011, British journal of pharmacology.

[11]  K. Mortensen,et al.  Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies. , 2011, The Biochemical journal.

[12]  N. Brünner,et al.  Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1 , 2011, Expert review of molecular diagnostics.

[13]  C. Koziol-White,et al.  Airway smooth muscle and immunomodulation in acute exacerbations of airway disease , 2011, Immunological reviews.

[14]  M. Schuliga,et al.  Plasminogen activation by airway smooth muscle is regulated by type I collagen. , 2011, American journal of respiratory cell and molecular biology.

[15]  Bihui Huang,et al.  Feedback Regulation of Endothelial Cell Surface Plasmin Generation by PKC-dependent Phosphorylation of Annexin A2* , 2010, The Journal of Biological Chemistry.

[16]  J. Shute,et al.  Up-regulation of the Extrinsic Coagulation Pathway in Acute Asthma—A Case Study , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[17]  C. Lemière,et al.  Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. , 2010, The Journal of allergy and clinical immunology.

[18]  R. Gosens,et al.  Cigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype , 2010, Respiratory research.

[19]  C. Ruppert,et al.  Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model. , 2010, American journal of respiratory and critical care medicine.

[20]  J. Hamilton,et al.  Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement , 2010, Arthritis research & therapy.

[21]  Silvia M Bacot,et al.  Annexin A2 tetramer activates human and murine macrophages through TLR4. , 2010, Blood.

[22]  M. Schuliga,et al.  Airway smooth muscle remodels pericellular collagen fibrils: implications for proliferation. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[23]  E. Walters,et al.  Increased vascular permeability precedes cellular inflammation as asthma control deteriorates , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  B. Camoretti-Mercado.  Targeting the airway smooth muscle for asthma treatment. , 2009, Translational research : the journal of laboratory and clinical medicine.

[25]  D. Postma,et al.  PLAUR polymorphisms are associated with asthma, PLAUR levels, and lung function decline. , 2009, The Journal of allergy and clinical immunology.

[26]  M. Schuliga,et al.  Fibrillar collagen clamps lung mesenchymal cells in a nonproliferative and noncontractile phenotype. , 2009, American journal of respiratory cell and molecular biology.

[27]  Y. Kono,et al.  Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[28]  K. Kowal,et al.  Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients. , 2008, Folia histochemica et cytobiologica.

[29]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[30]  L. Wahl,et al.  Urokinase-Type Plasminogen Activator Stimulation of Monocyte Matrix Metalloproteinase-1 Production Is Mediated by Plasmin-Dependent Signaling through Annexin A2 and Inhibited by Inactive Plasmin1 , 2007, The Journal of Immunology.

[31]  E. Plow,et al.  Plasminogen is an important regulator in the pathogenesis of a murine model of asthma. , 2007, American journal of respiratory and critical care medicine.

[32]  A. James,et al.  Clinical relevance of airway remodelling in airway diseases , 2007, European Respiratory Journal.

[33]  W. Fay,et al.  Vascular functions of the plasminogen activation system. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[34]  T. Hudson,et al.  Association of urokinase-type plasminogen activator with asthma and atopy. , 2007, American journal of respiratory and critical care medicine.

[35]  D. V. Von Hoff,et al.  Identification of a novel inhibitor of urokinase-type plasminogen activator , 2007, Molecular Cancer Therapeutics.

[36]  I. Kohane,et al.  Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells. , 2006, American journal of respiratory cell and molecular biology.

[37]  E. Abraham,et al.  Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury1 , 2006, The Journal of Immunology.

[38]  G. Tuszynski,et al.  Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action. , 2006, Experimental and molecular pathology.

[39]  M. Bates,et al.  Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. , 2006, American journal of respiratory cell and molecular biology.

[40]  T. Syrovets,et al.  Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. , 2006, Blood.

[41]  R. Gosens,et al.  Bradykinin augments EGF-induced airway smooth muscle proliferation by activation of conventional protein kinase C isoenzymes. , 2006, European journal of pharmacology.

[42]  P. Howarth,et al.  Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. , 2006, The Journal of allergy and clinical immunology.

[43]  J. Stankova,et al.  Fibroblast Growth Factor 2 and Transforming Growth Factor β1 Synergism in Human Bronchial Smooth Muscle Cell Proliferation , 2006 .

[44]  N. Khalil,et al.  TGF-β1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases , 2006, Respiratory research.

[45]  M. Davies,et al.  Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway. , 2005, Surgery.

[46]  T. Resink,et al.  Urokinase signal transduction and its role in cell migration , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  Jason H T Bates,et al.  The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? , 2004, Journal of applied physiology.

[48]  U. Pendurthi,et al.  Plasmin Induces Cyr61 Gene Expression in Fibroblasts Via Protease-Activated Receptor-1 and p44/42 Mitogen-Activated Protein Kinase–Dependent Signaling Pathway , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[49]  A. Coutts,et al.  Release of biologically active TGF-beta from airway smooth muscle cells induces autocrine synthesis of collagen. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[50]  P. Carmeliet,et al.  Deficiency of Urokinase-Type Plasminogen Activator–Mediated Plasmin Generation Impairs Vascular Remodeling During Hypoxia-Induced Pulmonary Hypertension in Mice , 2001, Circulation.

[51]  D. Lúdvíksdóttir,et al.  Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. , 2000, American journal of respiratory and critical care medicine.

[52]  N. Jarjour,et al.  Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. , 1999, American journal of respiratory and critical care medicine.

[53]  A. Shinomiya,et al.  The Role of Annexin II Tetramer in the Activation of Plasminogen* , 1998, The Journal of Biological Chemistry.

[54]  A. Stewart,et al.  Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture , 1994, British journal of pharmacology.

[55]  S. Cederholm-Williams.  Concentration of plasminogen and antiplasmin in plasma and serum , 1981, Journal of clinical pathology.

[56]  E. Rozengurt,et al.  Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism , 1980, Nature.

[57]  H. Kwaan,et al.  The role of plasminogen-plasmin system in cancer. , 2009, Cancer treatment and research.

[58]  D. Skarecky,et al.  Annexin A2 positively contributes to the malignant phenotype and secretion of IL‐6 in DU145 prostate cancer cells , 2009, International journal of cancer.

[59]  David S. Rogers,et al.  Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. , 2008, American journal of respiratory cell and molecular biology.

[60]  J. Stankova,et al.  Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. , 2006, American journal of respiratory cell and molecular biology.

[61]  M. Davies,et al.  Plasmin induces smooth muscle cell proliferation. , 2005, The Journal of surgical research.

[62]  D. Loskutoff,et al.  Comparative studies of the fibrinolytic activity of cultured vascular cells. , 1979, Thrombosis research.